GLENMEDE TRUST CO NA - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 145 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 2.08 and the average weighting 0.3%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$246,000
-36.9%
4,406
-18.0%
0.00%0.0%
Q1 2022$390,000
-39.2%
5,375
-0.9%
0.00%
-33.3%
Q4 2021$641,000
-19.6%
5,426
-8.7%
0.00%
-25.0%
Q3 2021$797,000
-22.9%
5,944
-7.1%
0.00%
-20.0%
Q2 2021$1,034,000
+50.3%
6,396
-25.5%
0.01%
+25.0%
Q1 2021$688,000
+43.0%
8,585
-3.2%
0.00%
+33.3%
Q4 2020$481,000
+174.9%
8,8680.0%0.00%
+200.0%
Q3 2020$175,000
-29.7%
8,868
-25.8%
0.00%
-50.0%
Q2 2020$249,000
+128.4%
11,946
+58.3%
0.00%
Q1 2020$109,0000.0%7,5470.0%0.00%
Q4 2019$109,000
+153.5%
7,547
+125.5%
0.00%
Q3 2019$43,000
-4.4%
3,347
+21.7%
0.00%
Q2 2019$45,000
-2.2%
2,7500.0%0.00%
Q1 2019$46,000
+24.3%
2,7500.0%0.00%
Q4 2018$37,000
-56.5%
2,750
-11.3%
0.00%
Q2 2018$85,0003,1000.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders